Bruce M. Baron

1.2k total citations
38 papers, 967 citations indexed

About

Bruce M. Baron is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Bruce M. Baron has authored 38 papers receiving a total of 967 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 19 papers in Cellular and Molecular Neuroscience and 7 papers in Organic Chemistry. Recurrent topics in Bruce M. Baron's work include Neuroscience and Neuropharmacology Research (17 papers), Receptor Mechanisms and Signaling (9 papers) and Chemical Synthesis and Analysis (4 papers). Bruce M. Baron is often cited by papers focused on Neuroscience and Neuropharmacology Research (17 papers), Receptor Mechanisms and Signaling (9 papers) and Chemical Synthesis and Analysis (4 papers). Bruce M. Baron collaborates with scholars based in United States, Israel and Canada. Bruce M. Baron's co-authors include Jeffrey P. Whitten, Ian A. McDonald, Boyd L. Harrison, Barry W. Siegel, Laurie E. Lambert, Michael G. Palfreyman, John H. Kehne, Hsien C. Cheng, Niall S. Doherty and Timothy C. McCloskey and has published in prestigious journals such as Brain Research, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

In The Last Decade

Bruce M. Baron

37 papers receiving 897 citations

Peers

Bruce M. Baron
Kathy L. Kohlhaas United States
Ludo Kennis Belgium
Marina Alesiani Italy
Caroline Hicks United Kingdom
Florence Gaven France
H. Donald Burns United States
David G. Trist Italy
Z Kleinrok Poland
Mark D. Black United States
Armando García Canada
Kathy L. Kohlhaas United States
Bruce M. Baron
Citations per year, relative to Bruce M. Baron Bruce M. Baron (= 1×) peers Kathy L. Kohlhaas

Countries citing papers authored by Bruce M. Baron

Since Specialization
Citations

This map shows the geographic impact of Bruce M. Baron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce M. Baron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce M. Baron more than expected).

Fields of papers citing papers by Bruce M. Baron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce M. Baron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce M. Baron. The network helps show where Bruce M. Baron may publish in the future.

Co-authorship network of co-authors of Bruce M. Baron

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce M. Baron. A scholar is included among the top collaborators of Bruce M. Baron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce M. Baron. Bruce M. Baron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Zhuyin, et al.. (2003). Identification of Gap Junction Blockers Using Automated Fluorescence Microscopy Imaging. SLAS DISCOVERY. 8(5). 489–499. 45 indexed citations
2.
Baron, Bruce M., Boyd L. Harrison, John H. Kehne, et al.. (1997). Pharmacological characterization of MDL 105,519, an NMDA receptor glycine site antagonist. European Journal of Pharmacology. 323(2-3). 181–192. 40 indexed citations
3.
Petty, Margaret A., Jack Elands, Michael P. Johnson, et al.. (1997). The selectivity of MDL 74,721 in models of neurogenic versus vascular components of migraine. European Journal of Pharmacology. 336(2-3). 127–136. 8 indexed citations
4.
Siegel, Barry W., et al.. (1996). Activities of novel aryloxyalkylimidazolines on rat 5-HT2A and 5-HT2C receptors. European Journal of Pharmacology. 296(3). 307–318. 4 indexed citations
5.
Siegel, Barry W., Koti Sreekrishna, & Bruce M. Baron. (1996). Binding of the radiolabeled glycine site antagonist [3H]MDL 105,519 to homomeric NMDA-NR1a receptors. European Journal of Pharmacology. 312(3). 357–365. 26 indexed citations
6.
7.
Paulis, Tomas de, Jon R. Neergaard, Bruce M. Baron, et al.. (1995). Binding of 5H-Dibenzo[a,d]cycloheptene and Dibenz[b,f]oxepin Analogs of Clozapine to Dopamine and Serotonin Receptors. Journal of Medicinal Chemistry. 38(4). 708–714. 20 indexed citations
8.
Chapman, Astrid G., et al.. (1995). Anticonvulsant activity of a novel NMDA/glycine site antagonist, MDL 104,653, against kindled and sound-induced seizures. European Journal of Pharmacology. 274(1-3). 83–88. 26 indexed citations
9.
Salituro, Francesco G., Ronald Tomlinson, Bruce M. Baron, et al.. (1994). Enzyme-Activated Antagonists of the Strychnine-Insensitive Glycine/NMDA Receptor. Journal of Medicinal Chemistry. 37(3). 334–336. 35 indexed citations
10.
McClue, Steven J., Bruce M. Baron, & Bruce A. Harris. (1994). Activation of Gi protein by peptide structures of the muscarinic M2 receptor second intracellular loop. European Journal of Pharmacology Molecular Pharmacology. 267(2). 185–193. 21 indexed citations
11.
Whitten, Jeffrey P., Bruce M. Baron, & Ian A. McDonald. (1993). Competitive NMDA receptor antagonists; (R)-4-Oxo-5-phosphononorvaline structure-activity relationships. Bioorganic & Medicinal Chemistry Letters. 3(1). 23–26. 8 indexed citations
12.
Lambert, Laurie E., John F. French, Jeffrey P. Whitten, Bruce M. Baron, & Ian A. McDonald. (1992). Characterization of cell selectivity of two novel inhibitors of nitric oxide synthesis. European Journal of Pharmacology. 216(1). 131–134. 44 indexed citations
13.
Salituro, Francesco G., Boyd L. Harrison, Bruce M. Baron, et al.. (1992). 3-(2-Carboxyindol-3-yl)propionic acid-based antagonists of the NMDA (N-methyl-D-aspartic acid) receptor associated glycine binding site. Journal of Medicinal Chemistry. 35(10). 1791–1799. 55 indexed citations
14.
Baron, Bruce M., et al.. (1991). [3H]5,7-Dichlorokynurenic acid, a novel radioligand labels NMDA receptor-associated glycine binding sites. European Journal of Pharmacology Molecular Pharmacology. 206(2). 149–154. 62 indexed citations
15.
Lambert, Laurie E., Jeffrey P. Whitten, Bruce M. Baron, et al.. (1991). Nitric oxide synthesis in the CNS, endothelium and macrophages differs in its sensitivity to inhibition by arginine analogues. Life Sciences. 48(1). 69–75. 152 indexed citations
16.
Kehne, John H., Timothy C. McCloskey, Bruce M. Baron, et al.. (1991). NMDA receptor complex antagonists have potential anxiolytic effects as measured with separation-induced ultrasonic vocalizations. European Journal of Pharmacology. 193(3). 283–292. 112 indexed citations
17.
Whitten, Jeffrey P., et al.. (1990). (R)-4-Oxo-5-phosphononorvaline: a new competitive glutamate antagonist at the NMDA receptor complex. Journal of Medicinal Chemistry. 33(11). 2961–2963. 36 indexed citations
18.
Baron, Bruce M. & Barry W. Siegel. (1989). α2‐Adrenergic and Muscarinic Cholinergic Receptors Have Oposing Actions on Cyclic AMP Levels in SK‐N‐SH Human Neuroblastoma Cells. Journal of Neurochemistry. 53(2). 602–609. 21 indexed citations
19.
Baron, Bruce M., et al.. (1989). CT Features of Sarcoid Infiltration of a Lumbosacral Nerve Root. Journal of Computer Assisted Tomography. 13(2). 364–364. 15 indexed citations
20.
Baron, Bruce M. & Lee E. Limbird. (1988). Human platelet phospholipase A2 activity is responsive in vitro to pH and Ca2+ variations which parallel those occurring after platelet activation in vivo. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 971(1). 103–111. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kathy L. Kohlhaas Breakdown of academic impact, for papers by Ludo Kennis Breakdown of academic impact, for papers by Marina Alesiani Breakdown of academic impact, for papers by Caroline Hicks Breakdown of academic impact, for papers by Florence Gaven Breakdown of academic impact, for papers by H. Donald Burns Breakdown of academic impact, for papers by David G. Trist Breakdown of academic impact, for papers by Z Kleinrok Breakdown of academic impact, for papers by Mark D. Black Breakdown of academic impact, for papers by Armando García
Rankless by CCL
2026